|
1
|
Gramatzki D, Dehler S, Rushing EJ, Zaugg
K, Hofer S, Yonekawa Y, Bertalanffy H, Valavanis A, Korol D,
Rohrmann S, et al: Glioblastoma in the Canton of Zurich,
Switzerland Revisited: 2005 to 2009. Cancer. 122:2206–2215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu J, Wu W, Zhu B, Wang H, Liu R, Zhang X,
Li M, Yang Y, Yan J, Niu F, et al: Cerebral glioma grading using
bayesian network with features extracted from multiple modalities
of magnetic resonance imaging. PLoS One. 11:e1533692016.
|
|
3
|
Pessina F, Navarria P, Cozzi L, Ascolese
AM, Simonelli M, Santoro A, Tomatis S, Riva M, Fava E, Scorsetti M,
et al: Value of surgical resection in patients with newly diagnosed
grade III glioma treated in a multimodal approach: Surgery,
chemotherapy and radiotherapy. Ann Surg Oncol. 23:3040–3046. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sehm T, Fan Z, Ghoochani A, Rauh M,
Engelhorn T, Minakaki G, Dörfler A, Klucken J, Buchfelder M,
Eyüpoglu IY, et al: Sulfasalazine impacts on ferroptotic cell death
and alleviates the tumor microenvironment and glioma-induced brain
edema. Oncotarget. 7:36021–36033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bush NA, Chang SM and Berger MS: Current
and future strategies for treatment of glioma. Neurosurg Rev.
16:7–8. 2016.
|
|
6
|
Yin Q, Zhou YY, Wang P, Ma LI, Li P, Wang
XG, She CH and Li WL: CD44 promotes the migration of bone
marrow-derived mesenchymal stem cells toward glioma. Oncol Lett.
11:2353–2358. 2016.PubMed/NCBI
|
|
7
|
Garcia MA, Solomon DA and Haas-Kogan DA:
Exploiting molecular biology for diagnosis and targeted management
of pediatric low-grade gliomas. Future Oncol. 12:1493–1506. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lam FC and Yaffe MB: Kicking Genomic
Profiling to the Curb: How Re-wiring the Phosphoproteome Can
Explain Treatment Resistance in Glioma. Cancer Cell. 29:435–436.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun G, Yan SS, Shi L, Wan ZQ, Jiang N, Fu
LS, Li M and Guo J: MicroRNA-15b suppresses the growth and invasion
of glioma cells through targeted inhibition of cripto-1 expression.
Mol Med Rep. 13:4897–4903. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Belter A, Rolle K, Piwecka M,
Fedoruk-Wyszomirska A, Naskręt-Barciszewska MZ and Barciszewski J:
Inhibition of miR-21 in glioma cells using catalytic nucleic acids.
Sci Rep. 6:245162016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goodwin CR, Woodard CL, Zhou X, Pan J,
Olivi A, Xia S, Bettegowda C, Sciubba DM, Pevsner J, Zhu H, et al:
Microarray-based phospho-proteomic profiling of complex biological
systems. Transl Oncol. 9:124–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Ding H, Han Y, Sun D, Wang H and
Zhai XU: The significance of microRNA-184 on JAK2/STAT3 signaling
pathway in the formation mechanism of glioblastoma. Oncol Lett.
10:3510–3514. 2015.PubMed/NCBI
|
|
13
|
Liu Z, Mai C, Yang H, Zhen Y, Yu X, Hua S,
Wu Q, Jiang Q, Zhang Y, Song X, et al: Candidate tumour suppressor
CCDC19 regulates miR-184 direct targeting of C-Myc thereby
suppressing cell growth in non-small cell lung cancers. J Cell Mol
Med. 18:1667–1679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stringer BW, Bunt J, Day BW, Barry G,
Jamieson PR, Ensbey KS, Bruce ZC, Goasdoué K, Vidal H, Charmsaz S,
et al: Nuclear factor one B (NFIB) encodes a subtype-specific
tumour suppressor in glioblastoma. Oncotarget. 7:29306–29320. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Emdad L, Janjic A, Alzubi MA, Hu B,
Santhekadur PK, Menezes ME, Shen XN, Das SK, Sarkar D and Fisher
PB: Suppression of miR-184 in malignant gliomas upregulates SND1
and promotes tumor aggressiveness. Neuro Oncol. 17:419–429. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu TG, Wang L, Li W, Li JZ and Li J:
miR-143 inhibits oncogenic traits by degrading NUAK2 in
glioblastoma. Int J Mol Med. 37:1627–1635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng R and Dong L: Inhibitory effect of
miR-184 on the potential of proliferation and invasion in human
glioma and breast cancer cells in vitro. Int J Clin Exp Pathol.
8:9376–9382. 2015.PubMed/NCBI
|
